UBIQUITI INC. financials

UI CIK 0001511737

Source: EDGAR filings · Built 2026-06-02T04:16:14Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Free Cash Flow 627.44M 529.54M -166.36M 356.79M 593.70M 429.67M
EBITDA 858.18M 518.25M 560.86M 475.95M 754.69M 485.89M
Working Capital 462.37M 631.22M 815.23M 310.62M 417.74M 322.35M
Net Debt 397.69M 669.19M 1.06B 717.03M 309.60M 562.04M
Gross Margin 43.42% 38.36% 39.20% 39.59% 48.06% 47.35%
Operating Margin 32.50% 25.88% 28.06% 27.33% 39.12% 37.23%
Net Margin 27.66% 18.15% 21.01% 22.38% 32.48% 29.61%
Return on Equity (ROE) 106.53% 368.15% -352.23% -98.90% 22844.91% -128.71%
Return on Assets (ROA) 48.55% 30.32% 28.98% 44.83% 69.20% 51.57%
Current Ratio 1.65× 3.22× 3.32× 2.00× 2.51× 2.22×
Debt-to-Equity 0.82× 8.37× -10.17× -2.23× 207.12× -2.38×
Effective Tax Rate 11.63% 17.43% 16.18% 14.80% 15.26% 15.53%
Cash Conversion Ratio 0.90× 1.55× -0.36× 0.98× 0.99× 1.21×
Accruals Ratio 0.05× -0.17× 0.39× 0.01× 0.01× -0.11×
SBC % of Revenue 0.28% 0.33% 0.24% 0.21% 0.16% 0.22%
CapEx Coverage 50.85× 45.22× -6.95× 27.49× 33.40× 15.03×
Free Cash Flow Per Share $10.37 $8.76 $-2.75 $5.78 $9.42 $6.56

Valuation Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
P/E Trailing (Diluted) 35.00× 25.16× 26.08× 40.49× 31.92× 30.10×
P/FCF 39.72× 16.63× 42.94× 33.16× 26.62×
FCF Yield 2.52% 6.01% 2.33% 3.02% 3.76%
EV / EBITDA 29.48× 18.29× 20.83× 33.02× 26.30× 24.04×
P/S 9.68× 4.57× 5.47× 8.87× 10.29× 8.65×
P/B 37.26× 92.65× 7238.88×

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenue from Contract with Customer, Excluding Assessed Tax 2.57B 1.93B 1.94B 1.69B 1.90B
Revenues 2.57B 1.93B 1.94B 1.69B 1.90B 1.28B
Cost of Goods and Services Sold 1.46B 1.19B 1.18B 1.02B 985.82M
Cost of Revenue 1.02B 985.82M 676.33M
Gross Profit 1.12B 739.76M 760.73M 669.81M 912.28M 608.17M
Research and Development Expense 169.67M 159.77M 145.17M 137.69M 116.17M 89.41M
Selling, General and Administrative Expense 111.50M 81.00M 70.99M 69.86M 53.51M 40.57M
Operating Expenses 281.17M 240.76M 216.16M 207.55M 169.68M 129.97M
Operating Income (Loss) 836.28M 499.00M 544.57M 462.26M 742.59M 478.20M
Income Tax Expense (Benefit) 93.73M 73.87M 78.70M 65.79M 111.07M 69.90M
Net Income (Loss) Attributable to Parent 711.92M 349.96M 407.64M 378.66M 616.58M 380.30M
Earnings Per Share, Basic $11.77 $5.79 $6.75 $6.14 $9.79 $5.81
Weighted Average Number of Shares Outstanding, Basic 60.48M 60.45M 60.44M 61.69M 62.99M 65.43M
Earnings Per Share, Diluted $11.76 $5.79 $6.74 $6.13 $9.78 $5.80
Weighted Average Number of Shares Outstanding, Diluted 60.53M 60.46M 60.45M 61.72M 63.05M 65.51M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cash and Cash Equivalents, at Carrying Value 149.73M 126.34M 114.83M 136.22M 249.42M 142.62M
Assets, Current 1.17B 916.01M 1.17B 621.57M 694.16M 586.65M
Assets 1.47B 1.15B 1.41B 844.71M 890.99M 737.45M
Long-term Debt 250.00M 708.13M 1.08B 468.75M 493.75M 655.00M
Liabilities, Current 710.86M 284.79M 351.82M 310.95M 276.41M 264.30M
Long-term Debt, Excluding Current Maturities 0 669.88M 1.04B 762.62M 467.03M 628.44M
Liabilities 798.19M 1.06B 1.52B 1.23B 888.29M 1.03B
Stockholders' Equity Attributable to Parent 668.26M 95.06M -115.73M -382.88M 2.70M -295.46M
Common Stock, Shares, Outstanding 60.49M 60.46M 60.44M 60.42M 62.58M 63.69M

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash Provided by (Used in) Operating Activities 640.03M 541.52M -145.43M 370.26M 612.02M 460.28M
Payments to Acquire Property, Plant, and Equipment 12.59M 11.97M 20.93M 13.47M 18.32M 30.62M
Net Cash Provided by (Used in) Investing Activities -12.59M -11.97M -20.93M -11.18M -19.27M 69.58M
Payments for Repurchase of Common Stock 0 0 618.13M 219.76M 700.13M
Payments of Dividends 145.15M 145.09M 145.04M 148.06M 100.81M 78.68M
Net Cash Provided by (Used in) Financing Activities -604.06M -518.02M 144.96M -472.27M -485.95M -625.40M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (UI CIK 0001511737), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

SLM

SLM Corp

BX

Blackstone Inc.

KALV

KalVista Pharmaceuticals, Inc.